Home Proteases PAD

PAD

Other Proteases Related Inhibitors

Proteasome HCV Protease HIV Protease Thrombin MMP Cysteine Protease Serine Protease Tyrosinase Glutaminase Neprilysin

Isoform-selective Products

Cat.No. Product Name Information Product Use Citations Product Validations
S7803 Gsk484 Hydrochloride GSK484 HCl, a benzoimidazole derivative, is a selective and reversible inhibitor of peptidylarginine deiminase 4 (PAD4) with IC50 of 50 nM in the absence of Calcium.
Cancer Cell, 2025, 43(1):69-85.e11
Biomolecules, 2025, 15(4)572
J Exp Clin Cancer Res, 2024, 43(1):319
S8141 Cl-amidine Cl-amidine is an irreversible pan-peptidylarginine deiminase (PAD) inhibitor with IC50 values of 5.9 ± 0.3 μM, 0.8 ± 0.3 μM, 6.2 ± 1.0 μM for PAD4, PAD1 and PAD3, respectively. Cl-amidine induces apoptosis.
Immunity, 2025, S1074-7613(25)00069-X
Cell Rep, 2025, 44(2):115226
Nat Commun, 2024, 15(1):8663
S9644 BMS-P5 BMS-P5, a potent selective pharmacological inhibitor of PAD4, is used to evaluate the effect of PAD4 inhibition on multiple myeloma (MM)-induced neutrophil extracellular trap (NET) formation.
E4995 Cl-amidine hydrochloride Cl-amidine hydrochloride is an orally active peptidylarginine deminase (PAD) inhibitor, with IC50 values of 0.8 μM, 6.2 μM and 5.9 μM for PAD1, PAD3, and PAD4, respectively. Cl-amidine hydrochloride induces apoptosis in cancer cells. Cl-amidine hydrochloride induces microRNA (miR)-16 (miRNA-16, microRNA-16) expression and causes cell cycle arrest. Cl-Amidine hydrochloride prevents histone 3 citrullination and neutrophil extracellular trap formation, and improves survival in a murine sepsis model[1][2][3][4][5].
S7802 GSK199 GSK199 is a reversible, specific inhibitor of peptidyl arginine deiminase 4 (PAD4), with an IC50 of 200 nM without calcium. It is involved in histone citrullination and neutrophil extracellular trap formation, making it useful for studying autoimmune, cardiovascular, and oncological diseases.